+
in $
+1.22%
Roblox Corporation
in $
+0.57%
Equitrans Midstream Corporation
ETRN RBLX
Price 12.42 62.05
Movement +$ 0.07 +$ 0.75
Market Cap. 5.4 B 40.7 B
Volume 194.2 M 7.3 M
Volume μ 9.2 M 8.0 M
EPS TTM 0.90 -1.63
P/E TTM 13.80 -38.07
Dividend Yield TTM 1% -%
Shares Outstanding 436 M 656 M
Earnings Call July 19, 2024 Feb. 6, 2025

Financial Comparison

Financial Statements
Click to show
RBLX
ETRN
    • 2024
    • 2023
    • 2022
    • 2020
    • 2019
    • 2018
Profitability
Industry Average
Profit Margin
-2.02% YoY
-171.01
-0.42
-0.41
Gross Margin
+1.85% YoY
0.64
0.75
0.77
Operating Margin
+7.69% YoY
-171.95
-0.42
-0.45
EBT Margin
-1.04% YoY
-171.17
-0.42
-0.41
ETR
-% YoY
-
-
EPS
+16.04% YoY
-0.98
-1.57
-1.87
EPS Dil.
+16.04% YoY
-0.98
-1.57
-1.87
ROA
+6.96% YoY
-0.05
-0.17
-0.19
ROE
+79.78% YoY
-7.47
-3.05
-15.10
ROIC
+52.87% YoY
-0.46
-0.50
-1.06
Takeaways
  • Positive 5Y revenue growth of +635.36% and -635.36% for the past 10 Years
  • The profit margin of -0.41 implies a positive signal, comparing the net margin against the industry avg. of -171.01
Market Prospects
P/E
+25.84% YoY
1.91
-18.14
-24.47
P/B
+85.01% YoY
187.11
55.39
369.43
P/TB
+85.01% YoY
187.11
55.39
369.43
Earnings Yield
-34.84% YoY
0.00
-0.06
-0.04
Other Metrics
EBITDA[in mil.]
+27.63% YoY
-
-760
-1,050
EBITDA Margin
+8.95% YoY
-171.75
-0.34
-0.38
WA[in mil.]
+3.39% YoY
-
595
616
WA Dil.[in mil.]
+3.39% YoY
-
595
616
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings ETRN RBLX
Earnings Call Oct. 29, 2024 Aug. 1, 2024
Avg. EPS Forecast 0.23 -0.37
Potential Delta 0 % %
Avg. Revenue Forecast - Mil. 898 Mil.
Potential Delta - % - %
Dividends
Company Average
Equitrans Midstream Corporation
$0.15
Industry Average
Oil & Gas Midstream
$0.51

Investor Relations

Index
RBLX
Annual Statement Feb. 21, 2024, midnight
Quarterly Statement Oct. 31, 2024, midnight
Next Earnings Call Feb. 6, 2025
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
ETRN
Annual Statement Feb. 20, 2024, midnight
Quarterly Statement July 19, 2024, midnight
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
FDA Filing n/a

Strategic Comparison

Risks & Opportunities
Risk Factors [Item 1A]
25x for ETRN

Feb. 20, 2024

The regulatory approval process for the construction of new transmission assets is very challenging, and, as demonstrated with the MVP pipeline, has resulted in significantly increased costs and delayed targeted in-service dates, and decisions by regulatory and/or judicial authorities in pending or potential proceedings relevant to the development of midstream assets, particularly any litigation instituted in the Fourth Circuit, such as regarding the MVP Southgate project and/or expansions or extensions of the MVP, are likely to impact our or the MVP Joint Venture's ability to obtain or maintain in effect all approvals and authorizations, including as may be necessary to complete certain projects in a timely manner or at all, or our ability to achieve the expected investment returns on the projects.